GlassScriptPhysician profile
Masahiro Ono
NPI 1962807222
$118,928.07
in general payments reported to CMS, 2019-2025
21 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,475 · 2020: $2,429 · 2021: $4,891 · 2022: $31K · 2023: $3,043 · 2024: $68K · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $56K · Travel and Lodging: $9,833 · Food and Beverage: $7,981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $56,100.00 |
| Travel and Lodging | $9,833.06 |
| Food and Beverage | $7,981.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $110,251.55 | 2019-2025 | Impella |
| Abbott Laboratories | $5,016.39 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Medtronic Vascular, INC. | $964.98 | 2019-2020 | |
| Transmedics, INC. | $892.40 | 2021 | |
| Bolton Medical INC | $457.36 | 2024-2025 | Gelweave, Relay Thoracic Stent-Graft With Plus Delivery System, Metacross Otw |
| Medtronic, INC. | $336.53 | 2021-2023 | Avalus |
| Impulse Dynamics (USA) INC. | $179.87 | 2022-2023 | Optimizer |
| Kls-Martin L.P. | $169.22 | 2022 | |
| Shockwave Medical, INC | $145.55 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $118.04 | 2020-2021 | |
| United Therapeutics Corporation | $92.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.85 | 2022 | |
| Alnylam Pharmaceuticals INC. | $50.08 | 2019 | |
| Merck Sharp & Dohme LLC | $46.71 | 2021-2022 | |
| Baxter Healthcare | $33.71 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $24.27 | 2019 | |
| Cvrx, INC. | $23.43 | 2022 | |
| Sandoz INC. | $21.50 | 2019 | |
| Boston Scientific Corporation | $17.79 | 2023 | Watchman |
| Janssen Pharmaceuticals, INC | $17.02 | 2020 | |
| Zimmer Biomet Holdings, INC. | $14.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masahiro Ono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.